Autolus Therapeutics plc
AUTL
$1.60
$0.021.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -227.22% | 3.63% | 17.76% | -33.16% | 64.23% |
| Total Depreciation and Amortization | 26.67% | 30.96% | 24.96% | 26.08% | 17.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 305.91% | 1,386.22% | -130.31% | -58.47% | -135.19% |
| Change in Net Operating Assets | 132.92% | -717.29% | -157.05% | -28.69% | -112.55% |
| Cash from Operations | -77.47% | 11.52% | -42.48% | -86.52% | -52.76% |
| Capital Expenditure | 107.96% | 54.03% | -765.28% | -1,446.53% | -652.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.00% | -- | -- | -- | -- |
| Cash from Investing | 122.56% | 470.71% | 11,504.88% | -11,072.05% | -25,870.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -69.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.99% | -- | 65.15% | -- | -- |
| Cash from Financing | -105.99% | -1,058.92% | 63.06% | -- | 130,365.22% |
| Foreign Exchange rate Adjustments | 101.54% | -109.50% | 303.03% | 400.25% | -491.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.19% | 22.12% | 153.40% | -125.34% | -2,502.23% |